Flexible Subscriptions to Match your Budget and Timeline See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Express Scripts

Last Updated: December 5, 2021

DrugPatentWatch Database Preview

Patent: 6,747,179

➤ Subscribe for complete access

« Back to Dashboard

Summary for Patent: 6,747,179
Title: Carbon dioxide-soluble polymers and swellable polymers for carbon dioxide applications
Abstract:A method for carrying out a catalysis reaction in carbon dioxide comprising contacting a fluid mixture with a catalyst bound to a polymer, the fluid mixture comprising at least one reactant and carbon dioxide, wherein the reactant interacts with the catalyst to form a reaction product. A composition of matter comprises carbon dioxide and a polymer and a reactant present in the carbon dioxide. The polymer has bound thereto a catalyst at a plurality of chains along the length of the polymer, and wherein the reactant interacts with the catalyst to form a reaction product.
Inventor(s): DeSimone; Joseph M. (Chapel Hill, NC), Birnbaum; Eva (Los Alamos, NM), Carbonell; Ruben G. (Raleigh, NC), Crette; Stephanie (Chapel Hill, NC), McClain; James B. (Durham, NC), McCleskey; T. Mark (Los Alamos, NM), Powell; Kimberly R. (Chapel Hill, NC), Romack; Timothy J. (Durham, NC), Tumas; William (Los Alamos, NM)
Assignee: North Carolina State University (Raleigh, NC) The University of North Carolina at Chapel Hill (Chapel Hill, NC) Regents of University of California (Oakland, CA)
Application Number:09/641,815
Patent Claims:see list of patent claims

Details for Patent 6,747,179

Applicant Tradename Biologic Ingredient Dosage Form BLA Approval Date Patent No. Expiredate
Recordati Rare Diseases, Inc. ELSPAR asparaginase For Injection 101063 1978-01-10 ⤷  Try it Free 2019-08-20
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Approval Date >Patent No. >Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Harvard Business School
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.